| Authors: |
Hasuo H; Department of Psychosomatic Medicine, Kansai Medical University, Osaka, Hirakata, Osaka, 573-1010, Japan., Ishiki H; Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Matsuda Y; Department of Psychosomatic Internal Medicine, NHO Kinki-Chuo Chest Medical Center, Sakai, 591-8555, Japan., Matsuoka H; Department of Psycho-Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Kosugi K; Department of Palliative Medicine, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan., Xing M; Department of Psychosomatic Medicine, Kansai Medical University, Osaka, Hirakata, Osaka, 573-1010, Japan., Akiyama Y; Department of Psychosomatic Medicine, Kansai Medical University, Osaka, Hirakata, Osaka, 573-1010, Japan., Matsumoto Y; Department of Palliative Therapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, 135-0063, Japan., Ishikawa H; Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan. |
